<DOC>
	<DOC>NCT01651572</DOC>
	<brief_summary>The purpose of this study is to determine the incidence of post-operative residual curarization in our patients and to determine if Cisatracurium and Rocuronium behave differently from each other in terms of residual curarization.</brief_summary>
	<brief_title>Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia</brief_title>
	<detailed_description />
	<mesh_term>Delayed Emergence from Anesthesia</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>general anaesthesia with need to use of neuromuscularblocking agents awakening and extubation of the patient in the operating room and permanence in the PACU for at least 60 minutes age 1880 surgical operations lasting at least 1 hour ASA class IIII possibility to apply TOFmonitoring with thumbacceleromyography women of childbearing age not using contraceptives women of childbearing age using contraceptives subjects unable to give a valid consent patients in emergency situations patients not awakened and not extubated in the operating room age above 80 years or under 18 years surgical operations lasting less than an hour ASA class IV impossibility to apply and/or perform TOFmonitoring neuromuscular diseases intake of therapies interfering with the neuromuscular function patients having contraindications for either studied drug pregnant women women who are breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Postoperative residual curarization</keyword>
	<keyword>Residual neuromuscular block</keyword>
	<keyword>Complications</keyword>
	<keyword>Postoperative</keyword>
	<keyword>Neuromuscular function</keyword>
	<keyword>Neuromuscular block</keyword>
</DOC>